Lancet Article Details Drug's Lack of Benefit for Head and Neck Cancer
February 19, 2025
February 19, 2025
NORMAN, Oklahoma, Feb. 19 -- The University of Oklahoma issued the following news release:
* * *
Lancet Article Details Drug's Lack of Benefit for Head and Neck Cancer
OKLAHOMA CITY, OKLA. - A physician-scientist at the University of Oklahoma is part of an international effort seeking new options for patients with head and neck cancer who cannot receive the standard chemotherapy drug cisplatin.
Because cisplatin can damage the kidneys and . . .
* * *
Lancet Article Details Drug's Lack of Benefit for Head and Neck Cancer
OKLAHOMA CITY, OKLA. - A physician-scientist at the University of Oklahoma is part of an international effort seeking new options for patients with head and neck cancer who cannot receive the standard chemotherapy drug cisplatin.
Because cisplatin can damage the kidneys and . . .